About this trial
The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
chronic kidney disease (stage >= 4)
Disqualifiers
None
Trial population
Persons with \>= stage 4 chronic kidney disease and residing in the Gard department of France.
Trial design
Ecologic or community
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
The prevalence of chronic kidney disease stage > = 4 in the Gard according to laboratory data (raw number)
The prevalence of chronic kidney disease stage > = 4 in the Gard according to laboratory data (%)
Secondary outcomes
The percentage of patients with CKD stage >= 4 correctly reported by participating nephrologists
For each nephrologist participating in the study, the % of patients with stage >=4 chronic kidney disease who are correctly declared
The % of patients with chronic kidney disease stage > = 4 in the Gard according to laboratory data and who are not seen by a nephrologist
Sponsors and contacts
Click on the lead sponsor to view all of their trials.